Treatment Advances in Prostate Cancer

ecancer
R

ASCO® 2023 Summary: "Latest in PARPi in Prostate Cancer - PROpel, TALAPRO-2, and MAGNITUDE Trials"

By ecancer FEATURING Rana McKay, Friederike Schlürmann, Gunhild von Amsberg
By ecancer FEATURING Rana McKay, Friederike Schlürmann, Gunhild von Amsberg
616 views
June 14, 2023
0 Comments
Login to view comments. Click here to Login
02:32

ASCO® 2023 Insights: "Prognostic Impact of PSA Nadir (n)≥0.1ng/mL Wi…

Dana-Farber Cancer Institute

P. Ravi

121 views
08:59

ASCO® 2023 Poster Sessions From Dr. Andrew Armstrong in Prostate Can…

Insights from 2023 ASCO® Annual Meeting

A. Armstrong

523 views
05:18

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

1.8K views
25:33

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Dana-Farber Cancer Institute

J. Berchuck, A. Choudhury

1.2K views
15:51

A Multidisciplinary Team Approach to Prostate Cancer

Judd Moul

296 views
06:49

ASCO GU 2023 DEAR Study: Real-World Use of Darolutamide, Enzalutamid…

ASCO GU 2023 Conference Coverage

D. George

371 views
21:19

2023 West Oncology Conference: Latest Updates in Advanced Prostate C…

2023 West Oncology Conference

B. Somer

188 views
22:10

ASCO GU 2023 Latest in HSPC

ecancer

E. Efstathiou, B. Hadaschik, G. Attard, H. Payne

168 views
12:39

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

ASCO GU 2023 Conference Coverage

C. Sternberg

1.4K views
25:38

Advances in the Treatment Landscape of Metastatic Prostate Cancer

OncoAlert

N. Agarwal

229 views
14:01

ASCO GU 2023 Active Surveillance for Favorable Intermediate-Risk Pro…

ASCO GU 2023 Conference Coverage

A. D'Amico

153 views
05:41

ARASENS Trial Updates: OS With Darolutamide vs. Placebo in Combinati…

Fred Saad

366 views
11:12

Phase 3 ARASENS Trial: Overall Safety & Incidences of Adverse Events…

E. David Crawford

2.1K views
34:51

In Pursuit of Precision Medicine for Prostate Cancer Patients: Recen…

Houston Methodist

E. Efstathiou

333 views
20:52

AR Antagonists for Prostate Cancer: Are They All Equal?

PROSCA & BLADDR 2022

B. Tombal

226 views
07:50

Treatment Approach for Patients With mCSPC

PrecisCa

M. Rettig

185 views
05:32

When to Use Genomic Testing for Prostate Cancer

PrecisCa

P. Patel

139 views
09:09

Evolving Management of Castration-Sensitive Metastatic Prostate Canc…

Robert Dreicer

446 views